Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbocysteine vs CPAP for Obstructive Sleep Apnea
NCT02015598Completed
- Sponsor
- Guangzhou Institute of Respiratory Health
- Start
- Dec 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of carbocisteine in obstructive sleep apnea syndrome (OSAS) (2 arms), sponsored by Guangzhou Institute of Respiratory Health. Primary endpoints: Change of polysomnography parameters at 6 weeks, Daytime sleepiness (EDS) at 6 weeks and 1 more. Started Dec 2013; status: completed.
02
Drugs
carbocisteine
03
Conditions
obstructive sleep apnea syndrome (OSAS)
Beyond the preview
Go deeper on NCT02015598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02015598.